Clinical Trials Directory

Trials / Unknown

UnknownNCT05322486

Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases

Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases Versus Chemotherapy Alone

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
State Scientific Centre of Coloproctology, Russian Federation · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Currently, the question remains whether palliative primary tumor resection could improve overall survival of minimally symptomatic patients with colorectal cancer and synchronous unresectable metastases. The aim of this study is to determine if there is an improvement in overall survival of palliative primary tumor resection followed by chemotherapy in minimally symptomatic patients with colorectal cancer and synchronous unresectable metastases compared to those of upfront chemotherapy/radiotherapy alone.

Detailed description

The present study is a single-center retrospective observational cohort study with a propensity score matching. Between 2016 and 2022 from our institutional database minimally symptomatic patients with colorectal cancer and synchronous unresectable metastases will be selected. Patients will be divided into two groups: 1. Surgical resection of the primary tumour before to systemic therapy 2. Systemic therapy without previous resection of the primary tumour. Propensity score matching (PSM) will be performed, to minimize the selection bias by adjusting variables that may affect the survival of patients. Categorical variables will be compared using the chi-square test or Fisher's exact test. Continuous variables will be compared using the Student's t-test or Mann-Whitney U test. Survival rate will be determined by using Kaplan-Meier analysis with a log-rank test. Univariate and multivariate analyses for survival will be conducted using Cox proportional hazard models. Statistical results will be considered significant at p values less than 0.05.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgery of the primary tumourSurgical resection of the colon tumour, R0. No surgical intervention on metastasis.
DRUGchemotherapyChemotherapy with or without biological drugs.

Timeline

Start date
2020-10-29
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2022-04-11
Last updated
2022-04-11

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05322486. Inclusion in this directory is not an endorsement.